Endo International Ordinary Shares reported $1.42M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Ani Pharmaceuticals ANIP:US USD 286.52M 213K
Bristol Myers Squibb BMY:US USD 39.32B 222M
Coherus Biosciences CHRS:US USD 473.67M 3.17M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
Heron Therapeutics HRTX:US USD 149.23M 52K
Hikma Pharmaceutical HIK:LN USD 1.28B 268M
Horizon Pharma HZNP:US USD 2.56B 2.3M
Lannett LCI:US USD 623.86M 4.51M
Ligand Pharmaceuticals LGND:US USD 76.74M 92K
Novartis NOVN:VX USD 27.91B 530M
Pacira Pharmaceuticals PCRX:US USD 689.47M 58.4M
Patterson Companies PDCO:US USD 662.91M 388K
Perrigo Ordinary Shares PRGO:US USD 4.11B 4.4M
Phibro Animal Health PAHC:US USD 476.23M 9.07M
Revance Therapeutics RVNC:US USD 380.04M 8.24M
Supernus Pharmaceuticals SUPN:US USD 401.97M 530K
Takeda 4502:JP JPY 4.29T 449.74B
Teva Pharmaceutical TEVA:IT USD 21.21B 54M
Xeris Pharmaceuticals Inc XERS:US USD 187.08M 48.57M
Zoetis ZTS:US USD 7.9B 1.34B